Velcade and pleural effusion Patient Reports February 11, 2012

Velcade Side Effects Report #5887934-6
Velcade side effect was reported by a Physician from UNITED STATES on Sept 05, 2008. Female patient, weighting 156.5 lb, was diagnosed with thyroid cancer

and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, nodal arrhythmia, pleural effusion. Velcade dosage: 1.3 MG/M3, IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5920012-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 01, 2008. Female patient, weighting 156.5 lb, was diagnosed with thyroid cancer

and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, nodal arrhythmia, pleural effusion. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5194863-2
Velcade side effect was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient, 66 years of age, weighting 149.9 lb, was diagnosed with small cell lung cancer metastatic and was treated with Velcade. After drug was administered, patient experienced the following side effects: heart rate increased, lymphadenopathy, pleural effusion, pulmonary mass. Velcade dosage: 1.60 MG/M2, INTRAVENOUS. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5989560-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: arteriosclerosis, atrial fibrillation

, fall

, hypotension, pleural effusion, pneumonia

, pulmonary embolism

, sepsis

, thrombocytopenia. Velcade dosage: 2MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6016927-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 11, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, chronic obstructive pulmonary disease, condition aggravated, fall

, hypotension, lung infiltration, pleural effusion, pneumonia

, pulmonary embolism

. Velcade dosage: 2 MG/M2, INTRAVEOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5505002-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Oct 31, 2007. Female patient, 62 years of age, weighting 107.4 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, non-small cell lung cancer, pleural effusion, pneumonia

, pulmonary oedema, renal failure acute, respiratory distress, troponin increased. Velcade dosage: 1.3 MG/M2 D1 AND 8 IV DRIP. Patient was hospitalized. Patient died on 10/20/2007.

Velcade Side Effects Report #5318495-8
Velcade side effect was reported by a Physician from ITALY on Apr 20, 2007. Male patient, 67 years of age, weighting 74.00 lb, was diagnosed with myelofibrosis and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, chronic obstructive pulmonary disease, fluid retention, hepatosplenomegaly, oedema peripheral, oxygen saturation decreased, pleural effusion, pulmonary congestion, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6046013-8
Velcade side effect was reported by a Physician from UNITED STATES on Jan 07, 2009. Male patient, 85 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, barrett's oesophagus, dehydration, gastritis erosive, pleural effusion, pyrexia, renal failure acute. Velcade dosage: 2.5 MG, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6067854-7
Velcade side effect was reported by a Physician from UNITED STATES on Jan 21, 2009. Male patient, 85 years of age, weighting 196.2 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, barrett's oesophagus, blood creatinine increased, body temperature increased, dehydration, dyspnoea, pleural effusion, thrombocytopenia. Velcade dosage: 2.5 MG/M2, INTRAVENOUS. During the same period patient was treated with ALKERAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5332906-3
Velcade side effect was reported by a Physician from JAPAN on May 08, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, hyponatraemia, liver disorder, nerve injury, neuropathy peripheral, oedema peripheral, platelet count decreased, pleural effusion, volvulus. Velcade dosage: unknown. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5912904-9
Velcade side effect was reported by a Physician from JAPAN on Sept 29, 2008. Male patient, 81 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, haemorrhage subcutaneous, myalgia, platelet count decreased, pleural effusion, pneumonia staphylococcal, respiratory failure, urinary retention. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with EPADEL, URSO, GLYCYRON, NORVASC, PRAVASTATIN, ALESION, DECADRON, PREDONINE. Patient died on 09/03/2008.

Velcade Side Effects Report #6111471-7
Velcade side effect was reported by a Physician from JAPAN on Feb 25, 2009. Male patient, 81 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure decreased, dysstasia, haemorrhage subcutaneous, muscular weakness, myalgia, platelet count decreased, pleural effusion, pneumonia

. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with EPADEL, URSO, GLYCYRON, NORVASC, PRAVASTATIN, ALESION, DECADRON, PREDONINE. Patient died on 09/03/2008.

Velcade Side Effects Report #5708421-1
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased, pleural effusion, pneumonia

, rash

. Velcade dosage: 2.00 MG, INTRAVENOUS : 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5728567-1
Velcade side effect was reported by a Physician from JAPAN on Apr 21, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

, pneumonia

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, laryngeal cancer, platelet count decreased, pleural effusion, pneumonia

, pyrexia, rash

, white blood cell count decreased. Velcade dosage: 2.00 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5633208-8
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, neurogenic bladder, neuropathy peripheral, platelet count decreased, pleural effusion, syncope. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5005828-5
Velcade side effect was reported by a Physician from UNITED STATES on May 01, 2006. Male patient, 75 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain

, anaemia, loss of consciousness, nausea

, pleural effusion, pulmonary oedema. Velcade dosage: unknown. Patient was hospitalized. Patient died on 01/12/2006.

Velcade Side Effects Report #5989751-5
Velcade side effect was reported by a Physician from JAPAN on Nov 26, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma

, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, melaena, pleural effusion, tumour lysis syndrome. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, WARFARIN, DECADRON, ALLOPURINOL, JUSO. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4818903-2
Velcade side effect was reported by a Physician from AUSTRALIA on Oct 21, 2005. Male patient, 74 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspiration, atelectasis, cardiomegaly, infection

, left ventricular failure, moraxella infection, pleural effusion, pleural fibrosis, pulmonary congestion. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with MS CONTIN, OXYCODONE, ONDANSETRON, FUROSEMIDE, FOLIC ACID. Patient was hospitalized. Patient died on 09/17/2005.

Velcade Side Effects Report #6084131-9
Velcade side effect was reported by a Physician from SPAIN on Feb 05, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: empyema, gastrointestinal haemorrhage, lobar pneumonia, neutropenia, pleural effusion, respiratory failure, sepsis

. Velcade dosage: 1.95 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769120-6
Velcade side effect was reported by a Physician from UNITED STATES on May 20, 2005. Male patient, 73 years of age, weighting 163.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, bone pain, epistaxis, pleural effusion, pneumonia

. Velcade dosage: 1.80 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5907654-9
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2008. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, multiple myeloma

, myocardial infarction, neuropathy peripheral, pleural effusion, thrombocytopenia. Velcade dosage: 2.2 MG; 1.6 MG. Patient died on 07/25/2008.

Velcade Side Effects Report #5225693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 12, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, bone marrow failure, haemorrhage, interstitial lung disease, pleural effusion, pneumonia aspiration. Velcade dosage: 1.80 MG; 1.40 MG. During the same period patient was treated with DECADRON, SAURAMIDE, FAMOTIDINE, SULFAMETHOXAZOLE, THALIDOMIDE. Patient died on 01/07/2007.

Velcade Side Effects Report #5228546-7
Velcade side effect was reported by a Physician from JAPAN on Jan 19, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, blood lactate dehydrogenase increased, bone marrow failure, haemorrhage, infection

, interstitial lung disease, oedema peripheral, pleural effusion, pneumonia aspiration. Velcade dosage: 1.80 MG, SEE IMAGE. During the same period patient was treated with DECADRON, SAURAMIDE, FAMOTIDINE, BAKTAR, THALIDOMIDE. Patient died on 01/07/2007.

Velcade Side Effects Report #5368126-6
Velcade side effect was reported by a Physician from JAPAN on June 06, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, hypovolaemia, platelet count decreased, pleural effusion, pyrexia, rash

. Velcade dosage: 2.20 MG,. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5404701-8
Velcade side effect was reported by a Physician from JAPAN on July 25, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5408154-5
Velcade side effect was reported by a Physician from JAPAN on July 26, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchitis

, herpes virus infection, pleural effusion. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5411164-5
Velcade side effect was reported by a Physician from JAPAN on July 27, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: condition aggravated, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5421861-3
Velcade side effect was reported by a Physician from JAPAN on Aug 07, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5451067-3
Velcade side effect was reported by a Physician from JAPAN on Aug 28, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchitis

, herpes virus infection, pleural effusion. Velcade dosage: 1.80MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, LOXOPROFEN, MUCOSTA, FAMOTIDINE, ALLOPURINOL, FUROSEMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5451071-5
Velcade side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, cardiac failure, hypotension, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5601977-9
Velcade side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 71 years of age, weighting 140.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cachexia, deep vein thrombosis

, pain

, pleural effusion, pneumonia

, pulmonary embolism

, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, THALIDOMIDE, ACYCLOVIR, LOMOTIL, ENULOSE, FENTANYL, MEGACE, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5634196-0
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, pyrexia, rash

, ventricular extrasystoles. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME, LEVOFLOXACIN. Patient recovered.

Velcade Side Effects Report #5679631-7
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, platelet count decreased, pleural effusion, pyrexia, rash

. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient died on 08/23/2007.

Velcade Side Effects Report #5698787-3
Velcade side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, rash

, ventricular extrasystoles. Velcade dosage: 1.9MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #5909042-8
Velcade side effect was reported by a Physician from JAPAN on Sept 19, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiomegaly, diarrhoea, enteritis infectious, neuropathy peripheral, oedema, pancytopenia, pleural effusion, pyrexia, rash

. Velcade dosage: 1.9 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #5074645-2
Velcade side effect was reported by a Physician from UNITED STATES on July 19, 2006. Female patient, 70 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, loss of consciousness, lung infiltration, pleural effusion, sepsis

, thrombocytopenia, urinary incontinence

, vomiting. Velcade dosage: unknown. Patient was hospitalized. Patient died on 04/30/2006.

Velcade Side Effects Report #4755112-X
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 10, 2005. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium increased, confusional state, diarrhoea, dilatation atrial, dilatation ventricular, electrocardiogram t wave inversion, myocardial ischaemia, pleural effusion, pulmonary hypertension

. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, ENOXAPARIN, OXYGEN, ALBUTEROL, ANTICOAGULANT CITRATE DEXTROSE, ANALGESICS. Patient was hospitalized. Patient died on 07/24/2005.

Velcade Side Effects Report #4898762-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2006. Female patient, 70 years of age, weighting 132.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: pleural effusion, pneumothorax. Velcade dosage: 1.30 MG, QD, INTRAVENOUS. During the same period patient was treated with TRISENOX, ASCORBIC ACID, LISINOPRIL, PLAVIX, ASPIRIN, VICODIN, VITAMIN NOS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4986495-3
Velcade side effect was reported by a Physician from UNITED STATES on Apr 10, 2006. Female patient, 70 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety

, cor pulmonale, pleural effusion, pulmonary hypertension

. Velcade dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, INDERAL, NEXIUM, OXYCONTIN, ATIVAN, WELLBUTRIN, RISPERDAL, LUNESTA. Patient recovered.

Velcade Side Effects Report #5006261-2
Velcade side effect was reported by a Physician from UNITED STATES on May 04, 2006. Female patient, 70 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety

, cardiac failure high output, cor pulmonale, dyspnoea, pleural effusion, pulmonary hypertension

. Velcade dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, INDERAL, NEXIUM, OXYCONTIN, ATIVAN, WELLBUTRIN, RISPERDAL, LUNESTA. Patient recovered.

Velcade Side Effects Report #5307739-4
Velcade side effect was reported by a Physician from UNITED STATES on Apr 04, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, atelectasis, chills, cough, dyspnoea, empyema, malaise, pleural effusion, pyrexia. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5347060-1
Velcade side effect was reported by a Physician from UNITED STATES on May 23, 2007. Male patient, 69 years of age, weighting 194.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, ejection fraction decreased, empyema, pleural effusion, pneumonia

, ventricular hypokinesia, weight decreased. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5740433-4
Velcade side effect was reported by a Physician from JAPAN on May 01, 2008. Male patient, 69 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: capillary leak syndrome, cardiac failure congestive, delirium, depressed level of consciousness, diastolic dysfunction, interstitial lung disease, nervous system disorder, pleural effusion, pulmonary oedema. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, AMLODIPINE BESYLATE, GLIMICRON, URSO, LANSOPRAZOLE, PURSENNID, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4712945-3
Velcade side effect was reported by a Physician from SINGAPORE on June 24, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiomegaly, haematocrit decreased, haemoglobin decreased, platelet count decreased, pleural effusion, pneumonia bacterial, red blood cell count decreased, white blood cell count decreased. Velcade dosage: 2.20 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized. Patient died on 06/19/2005.

Velcade Side Effects Report #4740365-4
Velcade side effect was reported by a Consumer or non-health professional from SINGAPORE on July 22, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacterial infection

, cardiomegaly, haematocrit decreased, haemoglobin decreased, platelet count decreased, pleural effusion, pneumonia

, red blood cell count decreased. Velcade dosage: 2.20 MG, 2 WEEK, INTRAVENOUS. Patient was hospitalized. Patient died on 06/19/2005.

Velcade Side Effects Report #5857241-6
Velcade side effect was reported by a Physician from JAPAN on Aug 14, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone marrow failure, dehydration, non-cardiogenic pulmonary oedema, pleural effusion, sepsis

, urine flow decreased. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIURETICS, DEXAMETHASONE. Patient died on 08/14/2008.

Velcade Side Effects Report #4700821-1
Velcade side effect was reported by a Health Professional from on June 27, 2005. Female patient, 67 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: difficult to wean from ventilator, hypertension, hypoxia, laboratory test abnormal, malignant neoplasm progression, multi-organ failure, multiple myeloma

, pleural effusion, renal failure. Velcade dosage: 1.6 MG/M2 INJECTION. During the same period patient was treated with THALIDOMIDE, LEVOTHYROXINE, OXYCONTIN, OXYCODONE, ACYCLOVIR, LEVEFLOXACIN, FLUCONAZOLE, LASIX. Patient died on 04/26/2005.

Velcade Side Effects Report #5704273-4
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 66 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cellulitis

, diarrhoea, erythema, hypogammaglobulinaemia, platelet count decreased, pleural effusion, septic shock, vomiting. Velcade dosage: 2.1 MG, INTRAVENOUS; 1.2 MG, INTRAVENOUS; 1.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ITRACONAZOLE, LEVOFLOXACIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LANSOPRAZOLE, IMIDAPRIL HYDROCHLORIDE. Patient recovered.

Velcade Side Effects Report #4939239-5
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2006. Female patient, 66 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: lung disorder, pleural effusion, pyrexia. Velcade dosage: unknown. Patient was hospitalized. Patient died on 11/26/2003.

Velcade Side Effects Report #5391764-1
Velcade side effect was reported by a Physician from FRANCE on July 05, 2007. Female patient, 65 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, atrial fibrillation

, confusional state, diarrhoea, disorientation, mucosal inflammation, pleural effusion, pneumonia

, respiratory distress. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, MELPHALAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5411257-2
Velcade side effect was reported by a Physician from VIET NAM on July 27, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone disorder, candidiasis, hypertension, left ventricular hypertrophy, pleural effusion, pneumonia

, sputum culture positive. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, TRAMADOL, LOMAC, ONDANSETRON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5874849-2
Velcade side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, multiple myeloma

, pleural effusion, renal failure, tumour lysis syndrome. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5244231-X
Velcade side effect was reported by a Physician from SPAIN on Feb 01, 2007. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hypotension, pleural effusion, pneumonia

, renal failure, right ventricular failure, somnolence. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5255394-4
Velcade side effect was reported by a Physician from SPAIN on Feb 16, 2007. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, cytolytic hepatitis, hypotension, pleural effusion, pneumonia

, renal failure, somnolence. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5663660-3
Velcade side effect was reported by a Physician from NETHERLANDS on Feb 27, 2008. Male patient, 64 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, atelectasis, gastroenteritis

, glomerulonephritis rapidly progressive, pleural effusion. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5707918-8
Velcade side effect was reported by a Physician from NETHERLANDS on Apr 02, 2008. Male patient, 64 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: ascites, atelectasis, diarrhoea, gastroenteritis

, glomerulonephritis rapidly progressive, pleural effusion. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5663494-X
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2008. Female patient, 63 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchial wall thickening, bronchiolitis, cardiac asthma, cough, pleural effusion, rales, respiratory disorder, rib fracture, wheezing. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, COMBIVENT, MS CONTIN, PROCARDIA, ATENOLOL, DILANTIN, ZOCOR, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5694196-1
Velcade side effect was reported by a Physician from JAPAN on Mar 21, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardiac failure, diarrhoea, disseminated intravascular coagulation, fungal infection

, hypoalbuminaemia, pleural effusion, pneumonia

. Velcade dosage: 2.00 MG; 1.50 MG. During the same period patient was treated with DEXAMETHASONE, MUCOSTA, AMPHOTERICIN B, RABEPRAZOLE, ZOLPIDEM TARTRATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ITRACONAZOLE. Patient was hospitalized. Patient died on 05/29/2007.

Velcade Side Effects Report #5214709-3
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: feeling hot, hypoaesthesia, metabolic acidosis, neuropathy, pleural effusion, pneumonia

, respiratory alkalosis, septic shock. Velcade dosage: 2.20 MG. Patient was hospitalized. Patient died on 12/29/2006.

Velcade Side Effects Report #5531304-7
Velcade side effect was reported by a Physician from JAPAN on Nov 19, 2007. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchial disorder, collapse of lung, lung disorder, pleural effusion. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5557234-2
Velcade side effect was reported by a Physician from JAPAN on Nov 30, 2007. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: lung disorder, pleural effusion. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5572376-3
Velcade side effect was reported by a Physician from JAPAN on Dec 14, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure, pleural effusion, respiratory tract haemorrhage. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 12/12/2007.

Velcade Side Effects Report #5587189-6
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, lung disorder, multiple myeloma

, oxygen saturation decreased, platelet count decreased, pleural effusion, respiratory disorder. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, WARFARIN, AMOBAN, FAMOTIDINE. Patient recovered.

Velcade Side Effects Report #5646861-X
Velcade side effect was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, 62 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: collapse of lung, lung disorder, oxygen saturation decreased, platelet count decreased, pleural effusion. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, WARFARIN, AMOBAN, FAMOTIDINE. Patient recovered.

Velcade Side Effects Report #5060265-2
Velcade side effect was reported by a Physician from JAPAN on July 13, 2006. Female patient, 61 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, hypoalbuminaemia, marrow hyperplasia, multiple myeloma

, musculoskeletal chest pain, pleural effusion, pyrexia, renal failure, respiratory failure. Velcade dosage: 1.80 MG/M2, INTRAVENOUS. During the same period patient was treated with FAMOTIDINE, ALFAROL, SULFAMETHOXAZOLE, OZEX, DIFLUCAN, MUCODYNE. Patient died on 07/01/2005.

Velcade Side Effects Report #4551812-5
Velcade side effect was reported by a Physician from on Dec 29, 2004. Male patient, 60 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: erythema multiforme, fatigue, pain in extremity, pleural effusion. Velcade dosage: 2.60 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with NAVOBAN, ZOMETA, VALTREX, BACTRIM, DIFLUCAN, TESTOSTERONE. Patient recovered.

Velcade Side Effects Report #5277959-6
Velcade side effect was reported by a Health Professional from SWEDEN on Mar 08, 2007. Female patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiomegaly, dialysis

, lymphadenopathy, pleural effusion, pulmonary hypertension

, pulmonary oedema, renal failure acute. Velcade dosage: 1.90 MG, UNK, INTRAVENOUS. During the same period patient was treated with ALVEDON, MOVICOL, LASIX RETARD, LORABID. Patient was hospitalized. Patient died on 01/01/2005.

Velcade Side Effects Report #5306515-6
Velcade side effect was reported by a Physician from JAPAN on Apr 06, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, ascites, blood lactate dehydrogenase increased, diarrhoea, haematemesis, hypoalbuminaemia, melaena, pleural effusion. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5678126-4
Velcade side effect was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal, hepatic neoplasm, leukaemia, multiple myeloma

, petechiae, platelet count decreased, pleural effusion, pneumonia

. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, ASPIRIN, METHYCOBAL, MAGNESIUM OXIDE, RED BLOOD CELLS, PLATELETS. Patient was hospitalized. Patient died on 10/03/2007.

Velcade Side Effects Report #4692459-X
Velcade side effect was reported by a Pharmacist from on Apr 05, 2005. Male patient, 59 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: pleural effusion. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with PREVACID. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4744340-5
Velcade side effect was reported by a Health Professional from SWEDEN on July 28, 2005. Female patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: dialysis

, dyspnoea, pleural effusion, pulmonary hypertension

, renal failure acute. Velcade dosage: 1.90 MG, INTRAVENOUS. Patient was hospitalized. Patient died.

Velcade Side Effects Report #4886598-8
Velcade side effect was reported by a Health Professional from SWEDEN on Jan 05, 2006. Female patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: dialysis

, disease progression, hepatomegaly, hypotension, lung disorder, lymphadenopathy, pleural effusion, pulmonary hypertension

. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with ALVEDON, MOVICOL, LASIX RETARD, LORABID. Patient was hospitalized. Patient died on 01/01/2005.

Velcade Side Effects Report #4931144-3
Velcade side effect was reported by a Physician from JAPAN on Feb 10, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, malignant pleural effusion, meningeal neoplasm, pleurisy, pneumonia

, pyrexia. Velcade dosage: unknown. Patient died on 10/18/2004.

Velcade Side Effects Report #4995825-8
Velcade side effect was reported by a Physician from JAPAN on Apr 21, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, meningeal disorder, multiple myeloma

, pleural effusion, pleurisy, pneumonia

, pyrexia. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. Patient died on 10/18/2004.

Velcade Side Effects Report #5042535-7
Velcade side effect was reported by a Physician from JAPAN on June 20, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion, pleurisy, pneumonia

, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 10/18/2004.

Velcade Side Effects Report #5704590-8
Velcade side effect was reported by a Physician from UNITED STATES on Mar 31, 2008. Male patient, 58 years of age, weighting 84.00 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, colitis, delirium, disease progression, fatigue, hypotension, pleural effusion. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ETOPOSIDE, ACYCLOVIR, SERTRALINE. Patient died on 06/22/2006.

Velcade Side Effects Report #5834757-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on July 23, 2008. Male patient, 58 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute abdomen, ascites, atelectasis, chills, diarrhoea, disseminated intravascular coagulation, multi-organ failure, pleural effusion, pyrexia. Velcade dosage: 2.4 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5877541-3
Velcade side effect was reported by a Physician from UNITED KINGDOM on Aug 27, 2008. Male patient, 58 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute abdomen, ascites, collapse of lung, diarrhoea, disseminated intravascular coagulation, multi-organ failure, neutropenic sepsis, pleural effusion, rectal haemorrhage. Velcade dosage: 2.4 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient died on 08/09/2008.

Velcade Side Effects Report #5914518-3
Velcade side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2008. Male patient, 58 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute abdomen, ascites, atelectasis, diarrhoea, disseminated intravascular coagulation, multi-organ failure, neutropenic sepsis, pleural effusion, rectal haemorrhage. Velcade dosage: 2.4 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient died on 08/09/2008.

Velcade Side Effects Report #5959602-3
Velcade side effect was reported by a Physician from JAPAN on Nov 07, 2008. Female patient, 57 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, atrial fibrillation

, flatulence, haematoma, ileus, pleural effusion, sick sinus syndrome, sinus arrest. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #4565843-2
Velcade side effect was reported by a Physician from on Jan 14, 2005. Male patient, 56 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, bronchopneumonia, cardiac failure, cardiopulmonary failure, pleural effusion, pulmonary oedema. Velcade dosage: 1.80 MG, QD, INTRAVENOUS. Patient died on 01/13/2005.

Velcade Side Effects Report #4715649-6
Velcade side effect was reported by a Physician from JAPAN on June 28, 2005. Male patient, 53 years of age, was diagnosed with multiple myeloma